CRISPR/Cas9-generated p47(phox)-deficient cell line for Chronic Granulomatous Disease gene therapy vector development

Development of gene therapy vectors requires cellular models reflecting the genetic background of a disease thus allowing for robust preclinical vector testing. For human p47(phox)-deficient chronic granulomatous disease (CGD) vector testing we generated a cellular model using clustered regularly in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wrona, Dominik, Siler, Ulrich, Reichenbach, Janine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347011/
https://www.ncbi.nlm.nih.gov/pubmed/28287132
http://dx.doi.org/10.1038/srep44187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347011/
https://www.ncbi.nlm.nih.gov/pubmed/28287132
http://dx.doi.org/10.1038/srep44187

Ejemplares similares